Overview

Gender

male

Jürg studied cultural anthropology in Venezuela, neuroscience and biochemistry (MSc) in Basel and the UK. He holds a PhD in Natural Sciences from ETH Zurich.



After postdoctoral studies with Prof. Karl-Heinz Altmann at the Institute of Pharmaceutical Sciences of the ETH Zurich, he became a group leader and was appointed track assistant professor in Bern in 2009. He was a visiting professor at the University of Cagliari (Italy) and Guadalajara (Mexico).

Since 2013, he is a full professor at the University of Bern for Membrane Biochemistry and Pharmacy. He is deputy and co-director of the Institute of Biochemistry and Molecular Medicine (IBMM) at the University of Bern and part of the management board of NCCR TransCure where he promotes Knowledge and Technology Transfer (KTT) activities.

His main research focus is on the molecular mechanisms of action of small organic compounds and natural products and their use as tools to understand biochemical processes. He has a strong interest in molecular pharmacology and the mechanistic role of the endocannabinoid system in inflammation and neuromodulation.

Jürg is co-author of 130+ scientific articles published in international peer-reviewed journals and acts as reviewer or editorial board member of different journals. Jürg is co-inventor on granted patents covering SERIs of first generation in Europe and of a second patent covering SERIs of first generation in the US. He is also an inventor of the two patent applications covering SERIs of second generation and several other patents.

In 2002, he was a co-founder of the ETH spin-off NaproMed Biopharmaceuticals. He serves as occasional consultant to the pharma industry and has several ongoing research collaborations with private companies related to analytics.